1. Home
  2. TG vs ABOS Comparison

TG vs ABOS Comparison

Compare TG & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tredegar Corporation

TG

Tredegar Corporation

HOLD

Current Price

$7.49

Market Cap

301.0M

Sector

Industrials

ML Signal

HOLD

Logo Acumen Pharmaceuticals Inc.

ABOS

Acumen Pharmaceuticals Inc.

HOLD

Current Price

$2.10

Market Cap

113.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TG
ABOS
Founded
1988
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
301.0M
113.9M
IPO Year
1989
2021

Fundamental Metrics

Financial Performance
Metric
TG
ABOS
Price
$7.49
$2.10
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
170.8K
147.0K
Earning Date
11-07-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$691,173,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$114.26
N/A
Revenue Growth
43.30
N/A
52 Week Low
$6.25
$0.86
52 Week High
$9.43
$2.46

Technical Indicators

Market Signals
Indicator
TG
ABOS
Relative Strength Index (RSI) 44.78 58.21
Support Level $7.49 $1.97
Resistance Level $7.90 $2.19
Average True Range (ATR) 0.26 0.13
MACD -0.04 0.03
Stochastic Oscillator 6.19 79.55

Price Performance

Historical Comparison
TG
ABOS

About TG Tredegar Corporation

Tredegar Corp, through its subsidiaries, engages in the manufacture of polyethylene plastic films, polyester films, and aluminum extrusions. Polyethylene plastic films produce plastic films, elastics, and laminate materials that are used in personal care products, surface protection films, and specialty and optical lighting applications. The company operates through segments including PE films, flexible packaging films, and aluminum extrusions. Aluminum extrusions generate the majority of revenue and provide high-quality, soft-alloy, medium-strength aluminum utilized in the building and construction, automotive, consumer durables, machinery and equipment, electrical, and distribution markets. Revenue is generated from the United States, Asia, and Brazil.

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.

Share on Social Networks: